Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial

To evaluate the effectiveness of dual trigger using gonadotropin-releasing hormone (GnRH) agonist and recombinant human chorionic gonadotropin (rHCG) versus rHCG alone for normal responders in GnRH antagonist intracytoplasmic sperm injection (ICSI) cycles. The current study was a registered open-lab...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gynecology obstetrics and human reproduction 2020-05, Vol.49 (5), p.101728-101728, Article 101728
Hauptverfasser:	Ali, Shymaa S., Elsenosy, Elwany, Sayed, Gamal H., Farghaly, Tarek A., Youssef, Ahmed A., Badran, Esraa, Abbas, Ahmed M., Abdelaleem, Ahmed A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Birth Rate Chorionic Gonadotropin - administration & dosage Dual trigger Egypt Embryo, Mammalian - drug effects Embryo, Mammalian - physiology Female Follicle Stimulating Hormone - administration & dosage GnRH agonist Gonadotropin-Releasing Hormone - agonists Gonadotropin-Releasing Hormone - antagonists & inhibitors Human chorionic gonadotropin Humans ICSI Infertility - therapy Oocyte Retrieval Oocytes - drug effects Oocytes - growth & development Ovulation Induction - methods Pregnancy Pregnancy Rate Recombinant Proteins - administration & dosage Sperm Injections, Intracytoplasmic Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!